Intervention Review

Drug treatment for facioscapulohumeral muscular dystrophy

  1. Michael R Rose1,*,
  2. Rabi Tawil2

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 19 APR 2004

Assessed as up-to-date: 9 JAN 2004

DOI: 10.1002/14651858.CD002276.pub2

How to Cite

Rose MR, Tawil R. Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002276. DOI: 10.1002/14651858.CD002276.pub2.

Author Information

  1. 1

    King's College Hospital, Department of Neurology, London, UK

  2. 2

    University of Rochester School of Medicine and Dentistry, Neuromuscular Disease Center, Rochester, New York, USA

*Michael R Rose, Department of Neurology, King's College Hospital, Academic Neuroscience Centre, Denmark Hill, London, SE5 9RS, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.